Imatinib and spironolactone suppress hepcidin expression.

about

Hepcidin is regulated by promoter-associated histone acetylation and HDAC3.Balance of cardiac and systemic hepcidin and its role in heart physiology and pathology.

P2860

Q41594444-3E017935-26A5-4006-9DC0-47658DE61085 Q48623654-FABED1A0-9D31-48E3-B898-848203B6711E

P2860

Imatinib and spironolactone suppress hepcidin expression.

Item

http://www.wikidata.org/entity/Q38708587

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Imatinib and spironolactone suppress hepcidin expression.

@en

type

Item

label

Imatinib and spironolactone suppress hepcidin expression.

@en

prefLabel

Imatinib and spironolactone suppress hepcidin expression.

@en

P1476

Imatinib and spironolactone suppress hepcidin expression.

@en

P2093

Ana Rita da Silva

http://www.w3.org/2001/XMLSchema#string

Daniel Seehofer

http://www.w3.org/2001/XMLSchema#string

Debora Call

http://www.w3.org/2001/XMLSchema#string

Georg Damm

http://www.w3.org/2001/XMLSchema#string

Joana Neves

http://www.w3.org/2001/XMLSchema#string

Martina U Muckenthaler

http://www.w3.org/2001/XMLSchema#string

Nikolai Schmeer

http://www.w3.org/2001/XMLSchema#string

P2860

DrugBank: a comprehensive resource for in silico drug discovery and exploration

STAT3 mediates hepatic hepcidin expression and its inflammatory stimulation

IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin

A simple practice guide for dose conversion between animals and human

SuperTarget and Matador: resources for exploring drug-target relationships

Identification of erythroferrone as an erythroid regulator of iron metabolism

Catalytic properties of NAD(P)H:quinone oxidoreductase-2 (NQO2), a dihydronicotinamide riboside dependent oxidoreductase

Two to tango: regulation of Mammalian iron metabolism

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

Drug repositioning: identifying and developing new uses for existing drugs

P304

1173-1184

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3324/HAEMATOL.2016.162917

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

102

http://www.w3.org/2001/XMLSchema#string

P50

Katarzyna Mleczko-Sanecka

P577

2017-04-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28385785

http://www.w3.org/2001/XMLSchema#string

P932

5566021

http://www.w3.org/2001/XMLSchema#string

Imatinib and spironolactone suppress hepcidin expression.

about

P2860

P2860

Imatinib and spironolactone suppress hepcidin expression.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932